Moreover, Novo Nordisk also claims that it is difficult to manufacture liraglutide and "even small changes in the manufacturing process of ... made a similar case for semaglutide in a petition ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
The list of 15 medicines includes blockbuster drugs from Novo Nordisk, Pfizer, Bristol Myers Squibb, AstraZeneca, GSK and other companies. Novo’s booming semaglutide franchise for diabetes and ...
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Novo Nordisk already has approval for semaglutide under the Wegovy brand for obesity, while Lilly is in the process of seeking approval to add weight loss to the label of Mounjaro. Both drugs are ...
The CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top ... in the U.S. Danish pharmaceutical giant Novo Nordisk is the manufacturer of Ozemipc; its diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback